Institutional investors purchased a net $641.7 thousand shares of DEPO during the quarter ended June 2017 and now own 95.81% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARMISTICE CAPITAL LLC Bought 1.6 Million shares of Depomed Inc
GEMMER ASSET MANAGEMENT LLC Bought 200.00 shares of Depomed Inc
QUADRANT CAPITAL GROUP LLC Bought 100.00 shares of Depomed Inc